| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2014-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b573955a02385ae439930678705347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca522bcb5779e48c5bf8ccf0e0ab01ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4ca472ce82cb88da7a53a03e463554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1727ef5752aafd960da3f0e90961f5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50fc22d2b03f2501cbd6dd6da6320ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19bd2ae30481857423422c88cbac959d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832fe6ea46bf878128faa03fd68e73d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4caf16ca891189c0e030295a41f405ee |
| publicationDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2897279-C |
| titleOfInvention |
Aminopyrazine derivatives and pharmaceutical compositions thereof for use in the treatment of cancer |
| abstract |
The invention concerns compounds of Formula (I) (Formula (I)) or pharmaceutically-acceptable salts thereof, wherein R1 and R2 have any of the meanings defined herein before in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders. |
| priorityDate |
2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |